• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

减少伤害:以澳大利亚为例的研究

Harm reduction: Australia as a case study.

作者信息

Wodak A

机构信息

Alcohol and Drug Service, St. Vincent's Hospital, Darlinghurst, NSW, Australia.

出版信息

Bull N Y Acad Med. 1995 Winter;72(2):339-47.

PMID:10101374
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2359449/
Abstract

This paper explicates the term, "harm reduction"; demonstrates that harm reduction has a long tradition; and uses one country, Australia, as a case study. Harm reduction can be understood as "policies and programs which are designed to reduce the adverse consequences of mood altering substances without necessarily reducing their consumption"; it is consistent with the best traditions of both medicine and public health. Although it is difficult to interpret trends in mortality from alcohol, tobacco, and illicit drugs to determine whether harm reduction in Australia "worked", the effectiveness of harm-reduction policies and programs in controlling HIV among injecting drug users (IDUs) seems extremely strong and suggests that benefits of harm-reduction programs for other drugs will become apparent in time.

摘要

本文阐述了“减少伤害”这一术语;表明减少伤害有着悠久的传统;并以澳大利亚这一国家为例进行研究。减少伤害可被理解为“旨在减少改变情绪物质的不良后果而不一定减少其消费量的政策和项目”;它与医学和公共卫生的最佳传统相一致。尽管很难解读酒精、烟草和非法药物导致的死亡率趋势来确定澳大利亚的减少伤害措施是否“奏效”,但减少伤害政策和项目在控制注射吸毒者中的艾滋病毒方面的有效性似乎非常显著,这表明减少伤害项目对其他药物的益处迟早会显现出来。

相似文献

1
Harm reduction: Australia as a case study.减少伤害:以澳大利亚为例的研究
Bull N Y Acad Med. 1995 Winter;72(2):339-47.
2
The effectiveness of harm reduction in preventing HIV among injecting drug users.减少伤害措施在预防注射吸毒者感染艾滋病毒方面的有效性。
N S W Public Health Bull. 2010 Mar-Apr;21(3-4):69-73. doi: 10.1071/NB10007.
3
A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs.酒精、烟草及非法药物危害减少策略的疗效与效果综述
Drug Alcohol Rev. 2006 Nov;25(6):611-24. doi: 10.1080/09595230600944529.
4
Taming demons: the reduction of harm resulting from use of illicit drugs.驯服恶魔:减少使用非法药物所造成的危害。
Aust N Z J Med. 1992 Apr;22(2):204-8. doi: 10.1111/j.1445-5994.1992.tb02814.x.
5
Malaysia and harm reduction: the challenges and responses.马来西亚与减少伤害:挑战与应对措施
Int J Drug Policy. 2007 Mar;18(2):136-40. doi: 10.1016/j.drugpo.2006.12.015. Epub 2007 Jan 29.
6
The Harm Reduction Coalition.减少伤害联盟。
Newsline People AIDS Coalit N Y. 1998 Jun:27-34.
7
Harm reduction drug policies and practice: international developments and domestic initiatives. Overview of a symposium. March 22, 1995.减少伤害药物政策与实践:国际发展与国内举措。一场研讨会综述。1995年3月22日
Bull N Y Acad Med. 1995 Winter;72(2):335-8.
8
Measuring harm reduction: the effects of needle and syringe exchange programs and methadone maintenance on the ecology of HIV.衡量减少伤害:针头和注射器交换计划及美沙酮维持治疗对艾滋病毒生态的影响。
AIDS. 1998;12 Suppl A:S217-30.
9
Studies confirm effectiveness of harm reduction for people who inject drugs.
HIV AIDS Policy Law Rev. 2011 Oct;15(3):29.
10
Drug and alcohol user treatment/intervention services in Russia--a Western perspective.俄罗斯的药物和酒精使用者治疗/干预服务——西方视角
Subst Use Misuse. 1996 Jan;31(1):103-14. doi: 10.3109/10826089609045801.

引用本文的文献

1
HIV in injecting drug users in Asian countries: naltrexone implants are set to supersede harm minimisation.亚洲国家注射吸毒者中的艾滋病毒:纳曲酮植入剂即将取代危害最小化措施。
BMJ. 2005 Jan 15;330(7483):147; author reply 147. doi: 10.1136/bmj.330.7483.147.

本文引用的文献

1
HIV prevalence among IDUs in Australia: a methodological review.澳大利亚注射吸毒者中的 HIV 流行率:方法学综述。
Drug Alcohol Rev. 1993;12(2):175-84. doi: 10.1080/09595239300185611.
2
Harm reduction means what I choose it to mean.减少伤害的含义由我来定义。
Drug Alcohol Rev. 1995;14(3):269-71. doi: 10.1080/09595239500185341.
3
HIV infection and injecting drug users: from epidemiology to public health.
AIDS. 1990;4 Suppl 1:S105-9.